Atropos Health will further scale the automation of high-quality, personalized real-world evidence, leveraging Generative Artificial Intelligence (AI)
Palo Alto, CA – May 23, 2024 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care, has announced the completion of a $33M Series B funding round. The company will use the funds to:
Invest in Real-World Evidence for Value-Based Care (VBC) Decision-Making
Grow the Atropos Evidence™ Network Including Vertical Integrations with Oncology and Specialty Areas
Expand Investment in Atropos Health Generative AI Application ChatRWD™
“This funding round, which includes multiple major strategic stakeholders in the healthcare ecosystem, is validation that our platform is rapidly becoming the standard not only for automation and user experience, but also as the trusted quality layer between healthcare data and the critical evidence needed to better inform patient care, research, and policy.” – Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health.
-
Value Based Care: Succeeding in VBC is having high quality evidence that accelerates appropriate clinical decision-making for better patient outcomes. Following Atropos Health’s partnership with Arcadia, the solution is emerging as a critical piece of infrastructure for value-based care.
-
Atropos Evidence Network: Evidence is more important than ever – especially in oncology care. It’s evolving constantly and the stakes are incredibly high. Expanding the Evidence Network is about more high quality evidence for care.
-
ChatRWD: Built on GENEVA OS™, ChatRWD is the first AI-powered chat to database application for healthcare and life sciences. Since the beta launch in 2023, it has proven to cut observational research production from months to minutes, while maintaining precision, transparency, and producing rigorous evidence for healthcare.
The Series B funding was led by Valtruis, with participation from new strategic investors including Cencora Ventures, McKesson Ventures, and Merck Global Health Innovation Fund, along with existing investors Breyer Capital, Emerson Collective, and Presidio Ventures.
Read the full press release here
Media coverage:
Forbes: Billionaire Jim Breyer Is Backing This Health AI Startup With A Radical Approach To Data
Business Insider: Here’s the 22-slide pitch deck that got Atropos Health $33 million for its generative AI bot for doctors
Wall Street Journal: Versant Ventures, AstraZeneca Team Up to Bankroll SixPeaks Bio
Axios: Atropos Health hauls in $33M to further its stake in VBC
BizJournals: Atropos Health expanding care after closing funding round
STAT Newsletter: Stanford spinout Atropos raises $33 million
VentureBeat: McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
Fierce Healthcare: Atropos Health lands $33M to scale AI-powered real-world evidence, build out pharma partnerships
Crain’s New York Business: Atropos Health raises $33M Series B
Endpoints: Atropos Health raises $30M to arm doctors and pharma companies with evidence
Endpoints Newsletter: Endpoints HealthTech
FinSMEs: Atropos Health Raises $33M in Series B Funding
Modern Healthcare: Top digital health funding: Tuesday Health, Eir Partners
MobiHealthNews: Real-world data platform Atropos Health raises $33M
HIStalk: Acquisitions, Funding, Business, and Stock
Intelligence360: ATROPOS HEALTH RAISES $33M TO SCALE THE AUTOMATION OF HIGH-QUALITY, PERSONALIZED REAL-WORLD EVIDENCE LEVERAGING GENERATIVE AI
VC News Daily: Atropos Health Announces $33M Series B Round
HIT Consultant: Atropos Health Raises $30M to Improve Value-Based Care Through Real-World Evidence
CityBiz: Atropos Health Raises $33M Series B
Outsourcing Pharma: Atropos Health secures $33M series B funding to enhance generative AI in healthcare
AlleyWatch: The Weekly Notable Startup Funding Report: 5/28/24
Hospital Management: Healthcare data company Atropos Health receives $33m in Series B funding round
Vator News: Atropos Health raises $30M to improve value-based care through real world evidence
About Atropos Health:
Atropos Health is the developer of GENEVA OS™, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.
To learn more about Atropos Health, connect through LinkedIn or follow on X (Twitter) @AtroposHealth.